{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:12:41Z","timestamp":1770721961489,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.imlet.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T20:53:08Z","timestamp":1442436788000},"page":"80-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Cassandra A.","family":"DeMarshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Nagele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhirup","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimish K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Godsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L.","family":"Goldwaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Kosciuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umashanger","family":"Thayasivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Belinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Nagele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2015.09.010_bib0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.imlet.2015.09.010_bib0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","article-title":"Submandibular gland needle biopsy for the diagnosis of Parkinson disease","volume":"82","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.imlet.2015.09.010_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate blood proteome markers of Alzheimer\u2019s disease onset and progression: a systematic review and replication study","volume":"38","author":"Kiddle","year":"2014","journal-title":"J. Alzheimers Dis.: JAD"},{"key":"10.1016\/j.imlet.2015.09.010_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and -200b, potential Biomarkers for Alzheimers disease, regulate beta secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.imlet.2015.09.010_bib0025","first-page":"1","article-title":"Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer\u2019s disease","author":"McIntyre","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2015.09.010_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000330750","article-title":"A blood-based algorithm for the detection of Alzheimer\u2019s disease","volume":"32","author":"O\u2019Bryant","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.imlet.2015.09.010_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2010.11.054","article-title":"Identification of candidate IgG biomarkers for Alzheimer\u2019s disease via combinatorial library screening","volume":"144","author":"Reddy","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2015.09.010_bib0040","doi-asserted-by":"crossref","first-page":"430 43e1","DOI":"10.1016\/j.neurobiolaging.2010.12.001","article-title":"CSF alpha-synuclein does not differentiate between parkinsonian disorders","volume":"33","author":"Aerts","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.imlet.2015.09.010_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00702-011-0682-x","article-title":"Biomarker candidates of neurodegeneration in Parkinson\u2019s disease for the evaluation of disease-modifying therapeutics","volume":"119","author":"Gerlach","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.imlet.2015.09.010_bib0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.imlet.2015.09.010_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.imlet.2015.09.010_bib0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ene.12176","article-title":"Reduced alpha-synuclein levels in cerebrospinal fluid in Parkinson\u2019s disease are unrelated to clinical and imaging measures of disease severity","volume":"21","author":"van Dijk","year":"2014","journal-title":"Eur. J. Neurol.: Off. J. Eur. Fed. Neurol.Soc."},{"key":"10.1016\/j.imlet.2015.09.010_bib0065","doi-asserted-by":"crossref","first-page":"e32383","DOI":"10.1371\/journal.pone.0032383","article-title":"Diagnosis of Parkinson\u2019s disease based on disease-specific autoantibody profiles in human sera","volume":"7","author":"Han","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.imlet.2015.09.010_bib0070","doi-asserted-by":"crossref","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer\u2019s disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"Nagele","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2015.09.010_bib0075","first-page":"154","article-title":"Natural autoantibodies: from \u2018horror autotoxicus\u2019 to \u2018gnothi seauton\u2019","volume":"12","author":"Avrameas","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.imlet.2015.09.010_bib0080","doi-asserted-by":"crossref","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2015.09.010_bib0085","doi-asserted-by":"crossref","first-page":"J71","DOI":"10.1016\/j.jaut.2011.12.007","article-title":"Sex gender and autoimmunity","volume":"38","author":"Shoenfeld","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2015.09.010_bib0090","doi-asserted-by":"crossref","unstructured":"DATATOP: a multicenter controlled clinical trial in early Parkinson\u2019s disease. Parkinson study group. Arch. Neurol. 46, 1989, 1052\u20131060.","DOI":"10.1001\/archneur.1989.00520460028009"},{"issue":"October (1)","key":"10.1016\/j.imlet.2015.09.010_bib0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"10.1016\/j.imlet.2015.09.010_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000345605","article-title":"Molecular neuropsychology: creation of test-specific blood biomarker algorithms","volume":"37","author":"O\u2019Bryant","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.imlet.2015.09.010_bib0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology","volume":"10","author":"Sattlecker","year":"2014","journal-title":"Alzheimers dement.: J. Alzheimers Assoc."},{"key":"10.1016\/j.imlet.2015.09.010_bib0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2015.09.010_bib0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.105.594929","article-title":"Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models","volume":"115","author":"Zou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2015.09.010_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0192623310391481","article-title":"Prevalence estimates for latent neurodegenerative disease","volume":"39","author":"Montine","year":"2011","journal-title":"Toxicol. Pathol."},{"issue":"Suppl. 2","key":"10.1016\/j.imlet.2015.09.010_bib0125","doi-asserted-by":"crossref","first-page":"S656","DOI":"10.1002\/mds.22672","article-title":"When does Parkinson\u2019s disease begin?","volume":"24","author":"Gaig","year":"2009","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.imlet.2015.09.010_bib0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2011.05.027","article-title":"Progress in defining the premotor phase of Parkinson\u2019s disease","volume":"310","author":"Tolosa","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2015.09.010_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2011.06.020","article-title":"Motor and non-motor correlates of olfactory dysfunction in Parkinson\u2019s disease","volume":"310","author":"Berendse","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2015.09.010_bib0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement.: J Alzheimers Assoc."},{"key":"10.1016\/j.imlet.2015.09.010_bib0145","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","article-title":"Blood-based protein biomarkers for diagnosis of Alzheimer disease","volume":"69","author":"Doecke","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.imlet.2015.09.010_bib0150","doi-asserted-by":"crossref","first-page":"e34341","DOI":"10.1371\/journal.pone.0034341","article-title":"Multivariate protein signatures of pre-clinical Alzheimer\u2019s disease in the Alzheimer\u2019s disease neuroimaging initiative (ADNI) plasma proteome dataset","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2015.09.010_bib0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2009.03.008","article-title":"The tau of MARK: a polarized view of the cytoskeleton","volume":"34","author":"Matenia","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.imlet.2015.09.010_bib0160","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biocel.2010.07.016","article-title":"Tau protein: relevance to Parkinson\u2019s disease","volume":"42","author":"Lei","year":"2010","journal-title":"Int J. Biochem. Cell Biol."},{"key":"10.1016\/j.imlet.2015.09.010_bib0165","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.imlet.2015.09.010_bib0170","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.30232","article-title":"2nd, Shahrara S: Characterization of CCL19 and CCL21 in rheumatoid arthritis","volume":"63","author":"Pickens","year":"2011","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.imlet.2015.09.010_bib0175","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/art.22039","article-title":"Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis","volume":"54","author":"Hsu","year":"2006","journal-title":"Arthr. Rheum."},{"key":"10.1016\/j.imlet.2015.09.010_bib0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/exd.12371","article-title":"Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin","volume":"23","author":"Bech","year":"2014","journal-title":"Exp. Dermatol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:13:38Z","timestamp":1567185218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815300341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0165247815300341"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.09.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}